R-Biopharm Neugen Private Limited - Company Profile

It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 1997.
1997 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About R-Biopharm Neugen Private Limited

R-Biopharm Neugen Private Limited, a active private limited company, was established on 21 May 1997 in Hyderabad, Telangana, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U74220TG1997PTC098579. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹7.83 M.

Formerly known as Harmony Hi-Tech (Madras) Private Limited, Neugen Diagnostics India Private Limited. It upholds a compliant status. Employing 26 professional, Its leadership includes Shivani Bhadresh Desai (Director), Christian Moraeno Dreher (Director). Past directors included Subrahmanyam Chintalapati, Hariharan Ramalingam Balakrishnampathi, Padmakar Janardan Moghe. It holds ₹1.19 Cr open charges and no settled loans. Its latest AGM occurred on 27 June 2025, with the balance sheet filed on 31 December 2024. It is based at First Floor, Plot No.70/ Part 71, Road No 3, Ida, Phase I , Cherlapally, Hyderabad, Telangana, 500051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74220TG1997PTC098579

  • Registration Number

    098579

  • Incorporation Date

    21 May 1997

  • Authorized Capital

    ₹8.00 M

  • Paid-Up Capital

    ₹7.83 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.00 M
  • Paid Up Capital ₹ 7.83 M
  • Company Age 28 Year, 9 Months
  • Last Filing with ROC 31 Dec 2024
  • Open Charges ₹ 1.19 Cr
  • Revenue Growth **** -3.25%
  • Profit Growth **** -536.47%
  • Ebitda **** -102.71%
  • Net Worth -15.38%
  • Total Assets **** 2.32%
Company report

R-Biopharm Neugen Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into R-Biopharm Neugen Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at R-Biopharm Neugen Private Limited?
Current Directors
Name Designation Appointment Date Status
Shivani Bhadresh Desai Director 04 Mar 2021 Current
Christian Moraeno Dreher Director 24 Oct 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 31 Jan 2010 Past
Pramod Abcsdd Additional Director 15 Sep 2010 Past
Pramod Abcsdd Director 24 Oct 2013 Past
Pramod Abcsdd Director 24 Oct 2013 Past
Pramod Abcsdd Additional Director 16 Apr 2014 Past
Pramod Abcsdd Additional Director 29 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of R-Biopharm Neugen.

R-Biopharm Neugen Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.25% decrease. The company also saw a substantial fall in profitability, with a 536.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.38%.

R-Biopharm Neugen revenue growth over time
R-Biopharm Neugen profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -3.25%
*******
*******
*******
*******
Revenue from Operations
*******
 -5.83%
*******
*******
*******
*******
Total Assets
*******
 2.32%
*******
*******
*******
*******
Profit or Loss
*******
 -536.47%
*******
*******
*******
*******
Net Worth
*******
 -15.38%
*******
*******
*******
*******
EBITDA
*******
 -102.71%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of R-Biopharm Neugen?

In 2023, R-Biopharm Neugen had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹11,915,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Corporate Bank : 1.09 Cr
  • Others : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
04 May 2020 Others ₹1.00 M Open
18 Oct 2012 Corporate Bank ₹1.09 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at R-Biopharm Neugen?

R-Biopharm Neugen has a workforce of 26 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of R-Biopharm Neugen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R-Biopharm Neugen's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on R-Biopharm Neugen
Recent Activity within the Organization
  • Annual General Meeting

    R-Biopharm Neugen Private Limited last Annual general meeting of members was held on 27 Jun 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    R-Biopharm Neugen Private Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    The activity Shivani Bhadresh Desai was appointed as a Director was appointed as a Director on 04 Mar 2021 & has been associated with this company since 4 years 11 months . was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 1.00 M with Charge ID 100405168 was registered on 04 May 2020. was completed.

  • Director Appointment

    Christian Moraeno Dreher was appointed as a Director was appointed as a Director on 24 Oct 2013 & has been associated with this company since 12 years 4 months . was recorded as a recent event.

  • Charges

    The activity A charge with Corporate Bank amounted to Rs. 10.92 M with Charge ID 10385300 was registered on 18 Oct 2012. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of R-Biopharm Neugen Private Limited?

The CIN of R-Biopharm Neugen Private Limited is U74220TG1997PTC098579.

Where is R-Biopharm Neugen Private Limited headquartered?

R-Biopharm Neugen Private Limited is headquartered at First Floor, Plot No.70/ Part 71, Road No 3, Ida, Phase I , Cherlapally, Hyderabad, Telangana, 500051.

When was R-Biopharm Neugen Private Limited incorporated?

R-Biopharm Neugen Private Limited was incorporated on 21 May 1997.

Who are the current directors of R-Biopharm Neugen Private Limited?

The current directors of R-Biopharm Neugen Private Limited are

What is the primary industry of R-Biopharm Neugen Private Limited?

The primary industry of R-Biopharm Neugen Private Limited is Trade.

Is R-Biopharm Neugen Private Limited a listed company?

R-Biopharm Neugen Private Limited is unlisted.

What is the capital structure of R-Biopharm Neugen Private Limited?

The authorized capital of R-Biopharm Neugen Private Limited is ₹8.00 M, and the paid-up capital is ₹7.83 M.

What is the compliance status of R-Biopharm Neugen Private Limited?

The compliance status of R-Biopharm Neugen Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available